First Header Logo Second Header Logo

Search Results (42)

MatchTypeWhy
Access to gynecologic oncology care and the network adequacy standard.Academic Article Why?
Cancer care delivery research in gynecologic oncology.Academic Article Why?
Interactions with industry under the Sunshine Act: an example from gynecologic oncology.Academic Article Why?
Intraoperative Handoffs and Postoperative Complications Among Patients Undergoing Gynecologic Oncology Operations.Academic Article Why?
Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study.Academic Article Why?
Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study.Academic Article Why?
Obstetrics and Gynecology-Gynecologic OncologyDepartment Why?
Does surgical treatment of atypical endometrial hyperplasia require referral to a gynecologic oncologist?Academic Article Why?
A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study.Academic Article Why?
A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: a Gynecologic Oncology Group Study (GOG 146Q).Academic Article Why?
A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.Academic Article Why?
A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.Academic Article Why?
A phase II trial of topotecan in patients with advanced, persistent, or recurrent endometrial carcinoma: a gynecologic oncology group study.Academic Article Why?
A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study.Academic Article Why?
Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.Academic Article Why?
Per Page    Page  of 3last Nextnext
Prev
Search Criteria
  • Gynecologic
  • oncology
Filter by Type
_
Click "Why?" to see why an item matched the search.